Eslicarbazepine and prodrugs

Name
Eslicarbazepine and prodrugs
Accession Number
DBCAT004556
Description

Not Available

Drugs
DrugDrug Description
Eslicarbazepine acetateAn anticonvulsant agent used as an adjunct to treat partial-onset seizures in patients with inadequate clinical response to conventional antiepileptic therapy.
EslicarbazepineAn antiepileptic indicated as a monotherapy or adjunct therapy in the treatment of epilepsy.
Drugs & Drug Targets
DrugTargetType
Eslicarbazepine acetateCytochrome P450 2C19enzyme
Eslicarbazepine acetateCytochrome P450 3A4enzyme
Eslicarbazepine acetateP2X purinoceptor 4target
Eslicarbazepine acetateUDP-glucuronosyltransferase 1-1enzyme
EslicarbazepineUDP-glucuronosyltransferase 1-1enzyme
EslicarbazepineCytochrome P450 2C19enzyme
EslicarbazepineP2X purinoceptor 4target
EslicarbazepineCytochrome P450 3A4enzyme